Empower Advisory Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$120M Buy
342,412
+9,341
+3% +$3.33M 0.31% 59
2025
Q4
$109M Buy
333,071
+523
+0.2% +$166K 0.29% 66
2025
Q3
$93.8M Buy
332,548
+8,068
+2% +$2.34M 0.26% 77
2025
Q2
$90.6M Buy
324,480
+9,951
+3% +$2.82M 0.27% 74
2025
Q1
$98M Buy
314,529
+11,063
+4% +$3.27M 0.32% 59
2024
Q4
$79.1M Sell
303,466
-116,879
-28% -$34.7M 0.27% 76
2024
Q3
$135M Buy
420,345
+2,682
+0.6% +$877K 0.46% 41
2024
Q2
$130M Sell
417,663
-505
-0.1% -$148K 0.48% 40
2024
Q1
$119M Sell
418,168
-2,284
-0.5% -$668K 0.45% 46
2023
Q4
$121M Buy
420,452
+3,861
+0.9% +$1.05M 0.48% 40
2023
Q3
$112M Buy
416,591
+6,601
+2% +$1.65M 0.5% 35
2023
Q2
$91M Buy
409,990
+9,065
+2% +$2.1M 0.39% 52
2023
Q1
$98M Buy
+400,925
New +$98.4M 0.44% 42

Other funds holding AMGN

Empower Advisory Group's AMGN Position: Q1 2026 in Review

Empower Advisory Group increased its Amgen (AMGN) stake by 2.8% in Q1 2026, buying an estimated $3.33M and bringing the position to 342,412 shares worth $120M. The position accounts for 0.31% of the portfolio, ranked #59.

Empower Advisory Group first reported a position in AMGN in Q1 2023 and has held it in 13 quarters since. The position peaked at $135M in Q3 2024. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Empower Advisory Group held 342,412 shares of Amgen worth $120M as of Q1 2026.
  • Empower Advisory Group bought 9,341 Amgen shares in Q1 2026, an estimated $3.33M.
  • Amgen made up 0.31% of Empower Advisory Group's portfolio in Q1 2026, its #59 holding.
  • Empower Advisory Group first reported a position in Amgen in Q1 2023 and has held it in 13 quarters since.
  • Empower Advisory Group's Amgen position peaked at $135M in Q3 2024.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Empower Advisory Group's 13F filing for Q1 2026, filed 14 May 2026.